Skip to main content
Ch. 13 - The Genetic Code and Transcription
Chapter 13, Problem 29

RNAi is currently being tested as a therapeutic tool for genetic diseases and other conditions. Consider the following: cystic fibrosis caused by loss of function of the CFTR gene, HIV infection, and cancer caused by hyperactivity of a growth factor receptor. Which of these may be treatable by RNAi, and which not? Explain your reasoning.

Verified step by step guidance
1
span>Step 1: Understand the mechanism of RNA interference (RNAi). RNAi is a biological process where RNA molecules inhibit gene expression or translation, effectively silencing targeted genes. It is particularly useful for reducing the expression of genes that are overactive or harmful.</span
span>Step 2: Analyze cystic fibrosis. Cystic fibrosis is caused by a loss of function mutation in the CFTR gene. Since RNAi is used to silence gene expression, it would not be suitable for treating cystic fibrosis, as the condition is due to a lack of CFTR function, not an overexpression.</span
span>Step 3: Consider HIV infection. RNAi could potentially be used to target and silence viral genes necessary for HIV replication. This could help in reducing the viral load in infected individuals.</span
span>Step 4: Evaluate cancer caused by hyperactivity of a growth factor receptor. RNAi could be used to silence the overactive growth factor receptor gene, potentially reducing the proliferation of cancer cells.</span
span>Step 5: Conclude which conditions are treatable by RNAi. RNAi is suitable for conditions where gene silencing is beneficial, such as HIV infection and cancers caused by overactive genes, but not for conditions like cystic fibrosis, which require gene function restoration.</span

Verified Solution

Video duration:
1m
This video solution was recommended by our tutors as helpful for the problem above.
Was this helpful?

Key Concepts

Here are the essential concepts you must grasp in order to answer the question correctly.

RNA Interference (RNAi)

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression or translation, effectively silencing specific genes. This mechanism can be harnessed therapeutically to target and degrade mRNA from genes that are overactive or mutated, making it a promising approach for treating genetic diseases and conditions like cancer and viral infections.
Recommended video:
Guided course
06:59
RNA Interference

Gene Function and Loss of Function Mutations

Gene function refers to the specific role a gene plays in the body, including the production of proteins necessary for normal cellular processes. Loss of function mutations, such as those in the CFTR gene causing cystic fibrosis, result in the absence or malfunction of these proteins, which can be challenging to treat with RNAi since the underlying issue is not merely the presence of faulty mRNA but the lack of functional protein.
Recommended video:
Guided course
08:26
Functional Genomics

Targeting Oncogenes and Viral Genes

Oncogenes are genes that, when mutated or overexpressed, can lead to cancer by promoting uncontrolled cell growth. RNAi can effectively target these oncogenes or viral genes, such as those involved in HIV infection, by degrading their mRNA, thereby reducing the expression of harmful proteins and potentially reversing disease progression.
Recommended video:
Guided course
02:39
Bacteria and Viral Chromosome Structure
Related Practice
Textbook Question

Describe the role of two forms of RNA editing that lead to changes in the size and sequence of pre-mRNAs. Briefly describe several examples of each form of editing, including their impact on respective protein products.

270
views
Textbook Question

Substitution RNA editing is known to involve either C-to-U or A-to-I conversions. What common chemical event accounts for each?

316
views
Textbook Question

While miRNA response elements (MREs) may be located anywhere within an mRNA, they are most often found outside the coding region in the 5' or 3' UTR. Explain why this is likely the case given that miRNAs often target more than one mRNA.

331
views
Textbook Question

Explain how the expression of a single gene can be quickly, efficiently, and specifically shut down at the transcriptional, posttranscriptional, and posttranslational stages through the coordinated expression of a transcriptional repressor, an miRNA, and a ubiquitin ligase.

227
views
Textbook Question

Recent observations indicate that alternative splicing is a common way for eukaryotes to expand their repertoire of gene functions. Studies indicate that approximately 50 percent of human genes exhibit alternative splicing and approximately 15 percent of disease-causing mutations involve aberrant alternative splicing. Different tissues show remarkably different frequencies of alternative splicing, with the brain accounting for approximately 18 percent of such events [Xu et al. (2002). Nucl. Acids Res. 30:3754–3766].

Why might some tissues engage in more alternative splicing than others?

267
views
Textbook Question

Isoginkgetin is a cell-permeable chemical isolated from the Ginkgo biloba tree that binds to and inhibits snRNPs.

What types of problems would you anticipate in cells treated with isoginkgetin?

214
views